ATLASEikon Therapeutics (EIKN) earnings date: Nov 12, 2026
Eikon Therapeutics (EIKN) reports earnings for the quarter ended Sep 30, 2026 on Thu, Nov 12, 2026, after the close. Analysts expect EPS of -$1.74.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on EIKN
| Last price | $5.40 (+1.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.2% |
| Earnings beat history | Beat the EPS estimate in 0 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Eikon Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Eikon Therapeutics reports on Nov 12, 2026. One email the day before, with ATLAS’s read on Eikon Therapeutics. You can switch it off at any time.
Alert me before EIKN reportsFree to start. Creating an account takes under a minute.
Notify me when Eikon Therapeutics reports
Track EIKN free Add Eikon Therapeutics to a free ATLAS watchlist and see its next report date in one place.
EIKN earnings at a glance
| Next report (confirmed) | Thu, Nov 12, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.74 |
| Last report | Aug 13, 2026 · Miss |
| Beat rate (last 5 reports) | 0 of 5 (0%) |
| Average EPS surprise | -38.7% |
| Average move around a report | ±11.1% (last 5) |
| Sector | Healthcare · Biotechnology |
Eikon Therapeutics earnings history: last 5 reports
Eikon Therapeutics last reported on Aug 13, 2026: EPS of -$1.63 against an estimate of -$1.46 (-11.6% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$1.46 | -$1.63 | -11.6% | Miss | +6.1% |
| May 11, 2026 | -$1.22 | -$2.46 | -101.6% | Miss | +15.8% |
| Apr 16, 2026 | $1.15 | $1.15 | 0.0% | In line | +9.8% |
| Mar 30, 2026 | -$17.75 | -$26.23 | -47.8% | Miss | +7.9% |
| Mar 11, 2026 | -$1.30 | -$1.72 | -32.3% | Miss | -16.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for EIKN
See the fair value, the probability range and the earnings history of Eikon Therapeutics on its ATLAS page.
Eikon Therapeutics (EIKN) stock analysisPlans from €3.99 a month.
Eikon Therapeutics earnings: frequently asked questions
When does Eikon Therapeutics (EIKN) report earnings?
Eikon Therapeutics is scheduled to report on Thursday, November 12, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for EIKN?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.74 per share (USD). Estimates can change before the report.
How often does EIKN beat earnings estimates?
Of its last 5 reports with a recorded result, Eikon Therapeutics beat the EPS estimate 0 times; the average surprise was -38.7%. Past results do not predict the next one.
How much does EIKN move around earnings?
Over its last 5 reports the stock moved an average of 11.1% (absolute, from the close before the report day to the close after it), and finished higher 4 of 5 times.
Did Eikon Therapeutics beat earnings estimates last quarter?
Eikon Therapeutics last reported on Aug 13, 2026: EPS of -$1.63 against an estimate of -$1.46 (-11.6% surprise), a miss.
How much does EIKN usually move in a day?
On a normal trading day the ATLAS model puts EIKN’s one-day range at about ±6.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Nov 12, 2026
Educational information, not investment advice. Disclaimer